Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-6 of 6 for Celiac disease

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Assess the Safety and Tolerability of Single and Multiple Doses of KAN-101 in Celiac Disease Patients

    Rochester, MN

  2. Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients

    Rochester, MN

  3. A Trial to Determine Efficacy, Safety, and Tolerability of 6-weeks Treatment of Latiglutenase (IMGX003) Administration in Patients with Well-Controlled Celiac Disease

    Rochester, MN

  4. Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim

    Jacksonville, FL, Rochester, MN

  5. A Study to Evaluate the Effectiveness and Safety of Larazotide Acetate for the Relief of CeD Symptoms

    Rochester, MN

  6. Celiac Disease Registry

    Rochester, MN

.

Mayo Clinic Footer